HDX and NMR Core
HDX 和 NMR 核心
基本信息
- 批准号:10242903
- 负责人:
- 金额:$ 104.57万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-09-01 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:3-Dimensional5&apos Untranslated RegionsAchievementAddressAffectAffinityAmino Acid SequenceAnusBindingBinding SitesBiological ProcessC-terminalCollectionCommunicationComplexCryoelectron MicroscopyCustomDBL OncoproteinDNADataDatabasesDeuteriumDiseaseElderlyEnzyme InhibitionEvolutionFamilyFundingGoalsHIVHIV-1HIV-1 integraseHIV-1 proteaseHumanHydrogenIntegraseIntegrase InhibitorsIsotopesKineticsLengthLentivirusLigand BindingLigandsManuscriptsMass Spectrum AnalysisMolecular ConformationMolecular ProbesMotionNuclear Magnetic ResonanceNucleic AcidsPeptide FragmentsPolymerasePost-Translational Protein ProcessingPreparationProcessPropertyProtein ConformationProtein DynamicsProteinsRNARNA-Directed DNA PolymeraseReportingResearch PersonnelRoentgen RaysRoleSamplingScientistSpumavirusStructureTechniquesTechnologyTherapeutic InterventionThiophenesTransfer RNAViralVirusX-Ray Crystallographyaptamerbasedesigngag-pol Fusion Proteinsgenetic regulatory proteininhibitor/antagonistinnovationmembermolecular recognitionpol Gene Productsprotein complexprotein structureprototypequinolinereceptorresistance mutationsmall moleculetandem mass spectrometrytherapeutic proteintranscriptional coactivator p75viral RNA
项目摘要
Abstract
Proteins are dynamic molecules that undergo constant flexing and motion. Changes in protein conformation
and dynamics are important to molecular recognition and these changes occur during many key biological
processes including activation and inhibition of enzymes, ligand binding to receptors, posttranslational
modifications, and allosteric communication across protein-protein interfaces. All of these processes are
regulated through the structure and dynamics of the proteins within the functional complex. Thus, techniques to
study protein structure and dynamics are critical to the understanding of biological processes and to aid in
developing strategies to target proteins for therapeutic intervention in disease. The HDX-NMR Core will address
central goals of the HIVE Center that include characterization of HIV protein interactions among themselves,
with host molecules, or with small molecule probes. A key focus of HDX efforts will be the structure and dynamics
of the HIV-1 reverse transcriptase (RT) initiation complex, or RTIC, a large protein-nucleic acid complex
comprising RT (p66/p51 heterodimer), the primer-binding site region of the 5’ untranslated viral RNA (vRNA) and
a human tRNA (Project 3: Arnold, Musier-Forsyth, Griffin, Lyumkis, and Sarafianos). We will also investigate
the interactions of HIV-1 RT with members of the APOBEC3 (A3) family of restriction factors (most notably A3G),
which have been reported to suppress the polymerase activity of RT and will also be studied in Project 3. In
addition to the RTIC from lentivirus HIV-1, we will also investigate the RTIC of spumavirus prototype foamy virus
(PFV). We are taking a multifaceted approach towards understanding these important virus-host complex
interactions, using cryo-EM, X-ray crystallography, HDX, SAXS, and pre-steady state kinetic analyses. Among
the main questions addressable by HDX are: How does the vRNA/tRNA interact with RT compared to DNA/DNA
and DNA/RNA substrates (cryo-EM, X-ray, HDX, kinetics)? What is the role of RNA structure in this complex
and how does it interact with RT (cryo-EM, X-ray, HDX)? What are the dynamic properties of the initiation
complex (cryo-EM, SAXS, HDX, kinetics)? How do interactions in the HIV-1 and PFV RTICs differ? How does
HIV-1 RT interact with A3 proteins to contribute to HIV-1 restriction? HDX has been instrumental for studying
quinoline-based allosteric integrase (IN) inhibitor (ALLINIs) induced aberrant multimerization of full-length wild
type (WT) IN and its application will now be extended to examine how recently discovered (Core 4) thiophene-
based inhibitors alter the IN structure (Project 1). HDX-MS will also be used to probe inter-protein interactions
among HIV-1 Gag and Gag-Pol proteins (Project 2), the effect of resistance mutations or inter-clade differences
in inter-protein interactions in HIV-1 proteins (Project 5), and interactions between HIV-1 proteins and SuFEx or
other small molecule probes (Project 6). NMR will be used to support Project 6 and Core 4.
摘要
蛋白质是动态的分子,经历不断的弯曲和运动。蛋白质构象的变化
和动力学对分子识别很重要,这些变化发生在许多关键的生物学过程中
包括酶的激活和抑制、与受体的配基结合、翻译后
修饰,以及跨蛋白质-蛋白质界面的变构通讯。所有这些过程都是
通过功能复合体内蛋白质的结构和动态进行调节。因此,一些技术可以
研究蛋白质的结构和动力学对于理解生物过程和帮助
开发针对疾病治疗干预的蛋白质的策略。HDX-核磁共振核心将解决
蜂巢中心的中心目标包括表征艾滋病毒蛋白质之间的相互作用,
用宿主分子,或用小分子探针。HDX工作的一个关键重点将是结构和动态
HIV-1逆转录酶(RT)起始复合体,或RTIC,一个大型的蛋白质-核酸复合体
包括RT(p66/p51异源二聚体)、5‘未翻译病毒RNA(VRNA)的引物结合部位区域和
一个人的tRNA(项目3:Arnold,Musier-Forsyth,Griffin,Lyumkis和Sarafianos)。我们还将调查
HIV-1RT与APOBEC3(A3)限制因子家族成员(尤其是A3G)的相互作用,
它们已经被报道抑制RT的聚合酶活性,也将在项目3中进行研究。
除了慢病毒HIV-1的RTIC外,我们还将研究SpumaVirus原型泡沫病毒的RTIC
(Pfv)。我们正在采取多方面的方法来理解这些重要的病毒-宿主复合体
相互作用,使用冷冻-EM、X射线结晶学、HDX、SAXS和稳态前动力学分析。其中
HDX可以解决的主要问题是:与DNA/DNA相比,vRNA/tRNA如何与RT相互作用
和DNA/RNA底物(冷冻-EM、X射线、HDX、动力学)?RNA结构在这个复合体中的作用是什么?
它是如何与RT(冷冻-EM、X射线、HDX)相互作用的?起爆的动力特性是什么?
复杂(冷冻-EM、SAXS、HDX、动力学)?HIV-1和PFV RTIC之间的相互作用有何不同?何以
HIV-1逆转录酶与A3蛋白相互作用促进HIV-1限制?HDX一直是研究的工具
喹啉类别构整合酶(IN)抑制剂(ALLINI)诱导野生型全长野生型细胞异常多聚体
(WT)IN类型及其应用现在将扩展到检查最近发现的(核心4)噻吩烯-
碱性抑制剂改变IN的结构(项目1)。HDX-MS还将用于探测蛋白质间的相互作用
在HIV-1 Gag和Gag-Pol蛋白(项目2)中,耐药突变或分支间差异的影响
HIV-1蛋白之间的相互作用(项目5),以及HIV-1蛋白与SuFEx或SuFEx之间的相互作用
其他小分子探针(项目6)。核磁共振将用于支持项目6和核心4。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Patrick Robert Griffin其他文献
Patrick Robert Griffin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Patrick Robert Griffin', 18)}}的其他基金
Quantifying and modeling ligand-dependent control of RORγ dynamics via structural proteomics
通过结构蛋白质组学对 RORγ 动力学的配体依赖性控制进行量化和建模
- 批准号:
10503840 - 财政年份:2022
- 资助金额:
$ 104.57万 - 项目类别:
Quantifying and modeling ligand-dependent control of RORγ dynamics via structural proteomics
通过结构蛋白质组学对 RORγ 动力学的配体依赖性控制进行量化和建模
- 批准号:
10704173 - 财政年份:2022
- 资助金额:
$ 104.57万 - 项目类别:
PPARG regulates osteocyte bioenergetics and function during aging
PPARG 在衰老过程中调节骨细胞生物能和功能
- 批准号:
10426408 - 财政年份:2021
- 资助金额:
$ 104.57万 - 项目类别:
PPARG regulates osteocyte bioenergetics and function during aging
PPARG 在衰老过程中调节骨细胞生物能和功能
- 批准号:
10317378 - 财政年份:2021
- 资助金额:
$ 104.57万 - 项目类别:
PPARG regulates osteocyte bioenergetics and function during aging
PPARG 在衰老过程中调节骨细胞生物能和功能
- 批准号:
10634739 - 财政年份:2021
- 资助金额:
$ 104.57万 - 项目类别:
Developing nonmuscle II inhibitors for substance use relapse
开发非肌肉 II 抑制剂治疗药物滥用复发
- 批准号:
9926588 - 财政年份:2019
- 资助金额:
$ 104.57万 - 项目类别:
Small molecules targeting hepatic glucose production and insulin resistance
针对肝葡萄糖生成和胰岛素抵抗的小分子
- 批准号:
9899246 - 财政年份:2019
- 资助金额:
$ 104.57万 - 项目类别:
Small molecules targeting hepatic glucose production and insulin resistance
针对肝葡萄糖生成和胰岛素抵抗的小分子
- 批准号:
10357876 - 财政年份:2019
- 资助金额:
$ 104.57万 - 项目类别:
Small molecules targeting hepatic glucose production and insulin resistance
针对肝葡萄糖生成和胰岛素抵抗的小分子
- 批准号:
10115706 - 财政年份:2019
- 资助金额:
$ 104.57万 - 项目类别:
Small molecules targeting hepatic glucose production and insulin resistance
针对肝葡萄糖生成和胰岛素抵抗的小分子
- 批准号:
10581523 - 财政年份:2019
- 资助金额:
$ 104.57万 - 项目类别:
相似国自然基金
晚期妊娠维持和抑制早产中cAMP信号活化PR的作用机制研究
- 批准号:81300507
- 批准年份:2013
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
相似海外基金
P1082 - Revealing Mercer 5's Pulsar Population with Parkes
P1082 - 揭秘默瑟 5
- 批准号:
Local : csiro:P1082 - 财政年份:
- 资助金额:
$ 104.57万 - 项目类别: